Recombinant Chicken Insulin-induced gene 2 protein (INSIG2) is a bioengineered variant of the endogenous INSIG2 protein, expressed through bacterial systems such as E. coli. This protein is critical for regulatory lipid metabolism and is produced for research applications in obesity, metabolic disorders, and sterol synthesis studies.
INSIG2 regulates cholesterol and fatty acid synthesis by inhibiting SREBP processing:
Mechanism: Binds to SCAP, preventing SCAP/SREBP complex transport to the Golgi, thereby blocking SREBP activation .
Regulation:
| Method | Details | Source |
|---|---|---|
| Recombinant Expression | E. coli with N-terminal His-tag for purification via metal affinity chromatography | |
| Purity | >85% (SDS-PAGE validated) |
ELISA Kits: Used as standard controls in lipid metabolism assays .
Biochemical Studies: Investigates INSIG2 interaction with SCAP/SREBP complexes .
Obesity Research: Links genetic variants near INSIG2 to obesity susceptibility .
Sterol Sensitivity: Unlike INSIG1, INSIG2 requires sterol presence to bind SCAP, enabling precise regulation .
Species-Specific Regulation: Human INSIG2 lacks liver-specific transcripts (Insig2a) present in rodents, affecting insulin responses .
Cancer Connection: Hypoxia-induced INSIG2 correlates with pancreatic cancer aggressiveness .
INSIG2 is an oxysterol-binding protein that regulates cholesterol biosynthesis through feedback control. It mediates this control by influencing both the endoplasmic reticulum (ER) to Golgi transport of SCAP and the degradation of HMGCR. Acting as a negative regulator of cholesterol biosynthesis, INSIG2 retains the SCAP-SREBP complex within the ER, thereby inhibiting the processing of sterol regulatory element-binding proteins (SREBPs). INSIG2 binds various oxysterols (including 22-hydroxycholesterol, 24-hydroxycholesterol, 25-hydroxycholesterol, and 27-hydroxycholesterol), modulating its interaction with SCAP and the retention of the SCAP-SREBP complex in the ER. In the presence of oxysterols, INSIG2 interacts with SCAP, preventing the transport of SREBPs to the Golgi. Sterol deprivation reduces oxysterol binding, disrupting the INSIG2-SCAP interaction, which facilitates Golgi transport of the SCAP-SREBP complex, leading to SREBP processing and nuclear translocation. INSIG2 also regulates cholesterol synthesis by modulating HMGCR degradation.
STRING: 9031.ENSGALP00000032298
UniGene: Gga.22921
Chicken INSIG2 provides unique advantages in cross-species experimental designs due to evolutionary distance from mammalian systems. When studying highly conserved regulatory pathways, chicken proteins offer distinctive experimental benefits compared to mammalian orthologs. First, chicken INSIG2 maintains core functional domains while exhibiting species-specific variations that can illuminate key structural-functional relationships. Second, using chicken proteins in mammalian systems can provide clearer experimental outcomes since chickens are approximately 100 million years evolutionarily removed from mammals, making their proteins more readily recognized as foreign in mammalian systems .
This evolutionary distance can be particularly advantageous when raising antibodies against INSIG2, as chickens tend to mount more robust immune responses against mammalian proteins that are highly conserved and might otherwise be weakly immunogenic in mammalian hosts . For experimental designs investigating protein-protein interactions or regulatory pathways, the chicken ortholog can provide complementary insights when used alongside mammalian versions, highlighting both conserved mechanisms and species-specific adaptations in lipid regulatory pathways.
When investigating INSIG2 function, true experimental research designs with proper controls yield the most reliable results. The experimental approach should incorporate the following key elements:
Control vs. Experimental Groups: Establish clearly defined control and experimental groups with random assignment of samples to minimize bias. For INSIG2 functional studies, include both wild-type controls and specific experimental groups with varied protein concentrations or mutated forms .
Variable Manipulation: Systematically manipulate independent variables while measuring dependent variables. For example, when studying INSIG2's role in lipid metabolism, independent variables might include INSIG2 concentration, presence of binding partners, or lipid substrate availability, while dependent variables could include lipid accumulation, gene expression changes, or protein localization patterns .
Randomization: Implement proper randomization techniques to control for extraneous variables. This is particularly important in complex cellular assays where multiple factors may influence outcomes .
A robust experimental design for INSIG2 functional studies might include:
| Group | Treatment | Control Type | Measurements |
|---|---|---|---|
| Control | No INSIG2 | Negative control | Baseline lipid metabolism |
| Low-dose | 0.1 μg/mL INSIG2 | Dose response | Lipid accumulation, gene expression |
| Medium-dose | 1.0 μg/mL INSIG2 | Dose response | Lipid accumulation, gene expression |
| High-dose | 10 μg/mL INSIG2 | Dose response | Lipid accumulation, gene expression |
| Mutant INSIG2 | 1.0 μg/mL mutated protein | Functional control | Comparative activity analysis |
This approach allows for systematic evaluation of dose-dependent effects while controlling for experimental variables that might otherwise confound results .
Investigating INSIG2 protein-protein interactions requires careful experimental design with appropriate controls and validation methods. A multi-technique approach is recommended:
In vitro binding assays: Using purified recombinant chicken INSIG2 protein, researchers should establish primary interaction profiles through pull-down assays. The His-tag on recombinant chicken INSIG2 facilitates immobilization on Ni-NTA resin for pull-down experiments .
Variable manipulation strategy: A factorial experimental design should be implemented, systematically varying factors such as:
Control implementation: Include multiple controls in each experiment:
Non-tagged protein controls to assess tag interference
Irrelevant proteins of similar size/structure to test specificity
Competitive binding controls with known ligands
Denatured protein controls to confirm structural specificity
For co-immunoprecipitation experiments, the chicken origin of INSIG2 provides an additional advantage, as chicken IgY antibodies can be used together with mammalian antibodies in multiplex detection systems without cross-reactivity concerns . This facilitates clearer visualization of protein complexes in co-IP experiments where multiple antibodies are required.
Proper storage and reconstitution of recombinant chicken INSIG2 is critical for maintaining protein integrity and experimental reproducibility. Follow these methodological guidelines:
Storage Protocol:
Store lyophilized protein at -20°C/-80°C upon receipt
After reconstitution, aliquot the protein to avoid repeated freeze-thaw cycles
For short-term use, working aliquots can be stored at 4°C for up to one week
For long-term storage, add glycerol to a final concentration of 50% and store at -20°C/-80°C
Reconstitution Protocol:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
For optimal stability, add glycerol to 5-50% final concentration
Gently mix by inversion rather than vortexing to prevent protein denaturation
Importantly, repeated freeze-thaw cycles significantly reduce protein activity and should be avoided through proper aliquoting. Working aliquots should be prepared in volumes appropriate for single experiments to prevent waste and quality degradation .
Validating the functionality of recombinant chicken INSIG2 requires a multi-faceted analytical approach. The following methodological framework ensures comprehensive functional validation:
Structural Integrity Assessment:
Functional Assays:
Lipid binding assays using fluorescently labeled lipids
SREBP cleavage-activating protein (SCAP) binding assays
Cholesterol-dependent protein interaction studies
Cellular Localization Validation:
Immunofluorescence microscopy using anti-His antibodies or specific INSIG2 antibodies
Subcellular fractionation followed by Western blotting
Co-localization studies with ER markers
For robust experimental design, include appropriate positive and negative controls:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive Control | Validate assay functionality | Known functional INSIG2 (e.g., human or mouse) |
| Negative Control | Establish baseline/background | Denatured protein or unrelated transmembrane protein |
| Tag Control | Assess tag interference | Untagged protein or alternatively tagged version |
| Species Control | Evaluate species-specific effects | Mammalian INSIG2 proteins for comparison |
When comparing functional outcomes across species, the evolutionary distance between chickens and mammals (>100 million years) should be considered as a factor that may influence protein-protein interactions, particularly for conserved metabolic pathways .
Recombinant chicken INSIG2 offers unique advantages in multiplex experimental systems due to its species origin and tagged format. When designing multiplex studies, researchers should implement the following methodological approach:
Multiplex immunostaining applications: Chicken-derived proteins provide exceptional utility in multiplex detection systems because chicken IgY antibodies can be used alongside mouse and rabbit antibodies without cross-reactivity concerns. Secondary antibodies against chicken IgY do not cross-react with mammalian IgG, enabling clear discrimination in complex co-localization studies .
Experimental design for multiplex systems:
Establish a true experimental design with appropriate controls
Systematically vary independent variables (INSIG2 concentration, lipid levels, presence of interacting proteins)
Control for confounding variables through randomization and blocking designs
Use factorial experimental designs to assess interaction effects between multiple variables
Implementation procedure:
Tag visualization: Utilize the His-tag for initial visualization and purification
Orthogonal detection methods: Combine fluorescence, chemiluminescence, and colorimetric detection for multiplexed readouts
Sequential probing strategies: Develop optimized stripping and reprobing protocols when using multiple antibodies
The advantage of chicken-derived recombinant proteins extends beyond antibody compatibility to include higher immunogenicity when used as antigens in mammalian systems, resulting in stronger experimental signals in many assay formats .
Investigating INSIG2's role in lipid metabolism requires sophisticated experimental design approaches that account for the protein's membrane localization and regulatory functions. Recommended methodological strategies include:
Experimental design framework:
Systematic analysis protocol:
Begin with in vitro binding studies using purified recombinant chicken INSIG2
Progress to cellular models with controlled expression systems
Validate key findings in appropriate tissue or organism models
Specialized assay methodology:
Lipidomic analysis to quantify changes in cellular lipid profiles
Real-time monitoring of SREBP pathway activation
Proximity ligation assays to detect INSIG2-SCAP interactions in situ
A comprehensive experimental approach should incorporate multiple time points and concentration gradients to capture dynamic regulatory effects:
| Experimental Condition | INSIG2 Status | Lipid Measurement | Gene Expression Analysis | Protein Interaction Study |
|---|---|---|---|---|
| Basal | Endogenous only | Baseline profiling | Housekeeping normalization | Background interactions |
| INSIG2 Overexpression | Recombinant addition | Differential analysis | Pathway-focused arrays | Co-IP and mass spectrometry |
| INSIG2 Inhibition | Blocking antibodies or inhibitors | Functional consequence | Regulatory network mapping | Disrupted interaction profiling |
| Stress Conditions | Under ER stress | Stress-responsive changes | Stress-induced regulation | Stress-dependent interactions |
When using recombinant chicken INSIG2, consider its evolutionary distance from mammalian systems as both an advantage (clearer discrimination of effects) and a potential limitation (species-specific interactions) that should be addressed through appropriate controls .
Working with recombinant chicken INSIG2 presents several technical challenges due to its membrane protein nature. Here are methodological approaches to address common issues:
Solubility limitations:
Challenge: As a transmembrane protein, INSIG2 has hydrophobic regions that can cause aggregation.
Solution methodology: Reconstitute lyophilized protein in buffers containing mild detergents (0.1% DDM or 0.5% CHAPS) to maintain solubility. For functional studies, consider reconstitution into nanodiscs or liposomes to provide a membrane-like environment .
Protein stability concerns:
His-tag interference:
Challenge: The N-terminal His-tag may affect protein function or interactions.
Solution methodology: Include parallel experiments with tag-cleaved protein using specific proteases. Alternatively, compare results with differently tagged versions to identify any tag-specific artifacts.
Species-compatibility issues:
Challenge: Chicken INSIG2 may interact differently with mammalian proteins in certain experimental systems.
Solution methodology: Leverage the evolutionary distance (>100 million years) as an experimental advantage. The distinct sequence of chicken INSIG2 can provide clearer results in conserved pathway studies, particularly for immunological applications .
An experimental troubleshooting decision matrix can guide researchers through common issues:
| Issue | Diagnostic Sign | First Intervention | Secondary Approach | Validation Method |
|---|---|---|---|---|
| Protein Aggregation | Visible precipitation, high MW bands on gels | Optimize detergent concentration | Try different buffer compositions | Dynamic light scattering |
| Activity Loss | Reduced binding in functional assays | Check protein concentration | Prepare fresh working stock | Positive control comparison |
| Non-specific Binding | High background in binding assays | Increase washing stringency | Add blocking agents (BSA, milk proteins) | Competition assays |
| Poor Reproducibility | Variable results between experiments | Standardize protein handling | Aliquot master stocks | Statistical analysis of replicates |
Optimizing protein-protein interaction studies with recombinant chicken INSIG2 requires methodological refinements to address its membrane protein nature and evolutionary distinctiveness. Follow this optimization protocol:
Buffer optimization strategy:
Systematically vary buffer components through a factorial experimental design
Test multiple pH conditions (6.5-8.0) to identify optimal interaction conditions
Evaluate different ionic strengths (50-500 mM NaCl) to minimize non-specific interactions
Incorporate detergent screens (non-ionic, zwitterionic, and mild ionic detergents) to maintain protein solubility without disrupting interactions
Experimental design for interaction specificity:
Multiplex detection advantages:
Leverage the chicken origin of the protein for multiplex detection systems
Chicken-derived proteins and antibodies can be used together with mouse and rabbit detection systems without cross-reactivity concerns
This enables more complex co-immunoprecipitation experiments with clearer discrimination of specific interactions
Validation methodology:
Confirm interactions using multiple orthogonal techniques
Start with in vitro pull-down assays using the His-tag
Validate with orthogonal methods like surface plasmon resonance
Confirm biological relevance with cellular co-localization studies
When optimizing these experiments, consider that the evolutionary distance between chicken and mammalian proteins can be advantageous for studying conserved interactions, as the core functional domains that maintain interactions across species are likely to represent fundamental biological mechanisms .
Emerging methodological approaches are expanding the potential for detailed INSIG2 functional characterization. Researchers should consider these innovative techniques:
Cryo-electron microscopy applications:
High-resolution structural analysis of INSIG2 in membrane environments
Visualization of INSIG2-SCAP-SREBP complexes in different conformational states
Combining the recombinant chicken INSIG2 with mammalian binding partners can provide unique insights into conserved structural elements versus species-specific adaptations
Advanced experimental design approaches:
CRISPR-based methodologies:
Precise genomic engineering to create endogenously tagged INSIG2 variants
Development of inducible degradation systems for temporal control of INSIG2 function
Creation of chimeric chicken-mammalian INSIG2 variants to map functional domains
Innovative protein engineering strategies:
Split-protein complementation assays for real-time interaction monitoring
Optogenetic control of INSIG2 function through light-responsive domains
Bioorthogonal labeling approaches for selective visualization in complex environments
The application of these emerging techniques should follow rigorous experimental design principles, including:
Clearly defined independent and dependent variables
Appropriate control systems
Randomization to minimize bias
When implementing these advanced approaches with recombinant chicken INSIG2, researchers should leverage its unique advantages, including extended shelf life (potentially 5 years or more at 4°C when properly prepared) compared to mammalian alternatives, which typically have more limited stability .